Baidu
map

NEJM:贲门失弛缓症的手术治疗

2019-12-05 MedSci MedSci原创

研究发现,在2年内,POSE在控制贲门失弛缓症的症状方面并不劣于LHM+的胃底折叠术。胃食管反流在接受POEM治疗的患者中更常见

气动扩张和腹腔镜海勒肌切开术(LHM)是治疗特发性贲门失弛缓症的有效方法。经口内镜下肌切开术(POEM)是一种微创治疗方法,早期研究效果显著。近日研究人员开展多中心随机研究,比较POEM与LHM在症状性贲门失弛缓症中的应用。

症状性贲门失弛缓症患者参与研究,随机接受POEM或LHM联合底折叠术治疗,研究的主要终点是临床治疗成功,定义为在2年随访中,在不使用额外治疗的情况下,Eckardt症状评分为3分或更少(范围为0至12分,分数越高表明贲门失弛缓症症状越严重)。次要终点包括不良事件、食管功能、肠生活质量指数评分(范围:0至144,较高评分表明较好的功能)和胃食管返流。

221例患者随机分为POSE组(112例)或LHM+胃底折叠术组(109例)。随访2年临床成功率:POSE组为83.0%,LHM组为81.7%(差异1.4个百分点,非劣效性P=0.007)。严重不良反应发生率:POSE组2.7%,LHM组7.3%。经食管下括约肌综合松弛压力、从基线到24个月的食管功能的改善,治疗组间差异无显著性,胃肠生活质量指数评分无显著差异。3个月时经内镜检查,POSE组57%和LHM组20%有反流性食管炎,24个月时相应百分比分别为44%和29%。

研究发现,在2年内,POSE在控制贲门失弛缓症的症状方面并不劣于LHM+的胃底折叠术。胃食管反流在接受POEM治疗的患者中更常见。

原始出处:

Yuki B. Werner et al. Endoscopic or Surgical Myotomy in Patients with Idiopathic Achalasia. N Engl J Med, December 5, 2019.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1747139, encodeId=affa1e47139e2, content=<a href='/topic/show?id=d9d192468dd' target=_blank style='color:#2F92EE;'>#贲门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92468, encryptionId=d9d192468dd, topicName=贲门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d50035925343, createdName=gostraight, createdTime=Fri Mar 06 00:12:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290724, encodeId=df9b1290e2423, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Dec 07 09:12:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503414, encodeId=d3461503414ef, content=<a href='/topic/show?id=b7ac924e0cc' target=_blank style='color:#2F92EE;'>#贲门失弛缓症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92470, encryptionId=b7ac924e0cc, topicName=贲门失弛缓症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9419632419, createdName=闆锋旦, createdTime=Sat Dec 07 09:12:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035038, encodeId=5c8a10350383e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Dec 05 21:12:00 CST 2019, time=2019-12-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1747139, encodeId=affa1e47139e2, content=<a href='/topic/show?id=d9d192468dd' target=_blank style='color:#2F92EE;'>#贲门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92468, encryptionId=d9d192468dd, topicName=贲门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d50035925343, createdName=gostraight, createdTime=Fri Mar 06 00:12:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290724, encodeId=df9b1290e2423, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Dec 07 09:12:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503414, encodeId=d3461503414ef, content=<a href='/topic/show?id=b7ac924e0cc' target=_blank style='color:#2F92EE;'>#贲门失弛缓症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92470, encryptionId=b7ac924e0cc, topicName=贲门失弛缓症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9419632419, createdName=闆锋旦, createdTime=Sat Dec 07 09:12:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035038, encodeId=5c8a10350383e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Dec 05 21:12:00 CST 2019, time=2019-12-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1747139, encodeId=affa1e47139e2, content=<a href='/topic/show?id=d9d192468dd' target=_blank style='color:#2F92EE;'>#贲门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92468, encryptionId=d9d192468dd, topicName=贲门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d50035925343, createdName=gostraight, createdTime=Fri Mar 06 00:12:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290724, encodeId=df9b1290e2423, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Dec 07 09:12:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503414, encodeId=d3461503414ef, content=<a href='/topic/show?id=b7ac924e0cc' target=_blank style='color:#2F92EE;'>#贲门失弛缓症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92470, encryptionId=b7ac924e0cc, topicName=贲门失弛缓症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9419632419, createdName=闆锋旦, createdTime=Sat Dec 07 09:12:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035038, encodeId=5c8a10350383e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Dec 05 21:12:00 CST 2019, time=2019-12-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1747139, encodeId=affa1e47139e2, content=<a href='/topic/show?id=d9d192468dd' target=_blank style='color:#2F92EE;'>#贲门#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92468, encryptionId=d9d192468dd, topicName=贲门)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d50035925343, createdName=gostraight, createdTime=Fri Mar 06 00:12:00 CST 2020, time=2020-03-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290724, encodeId=df9b1290e2423, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat Dec 07 09:12:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1503414, encodeId=d3461503414ef, content=<a href='/topic/show?id=b7ac924e0cc' target=_blank style='color:#2F92EE;'>#贲门失弛缓症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=92470, encryptionId=b7ac924e0cc, topicName=贲门失弛缓症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9419632419, createdName=闆锋旦, createdTime=Sat Dec 07 09:12:00 CST 2019, time=2019-12-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1035038, encodeId=5c8a10350383e, content=顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=旺医, createdTime=Thu Dec 05 21:12:00 CST 2019, time=2019-12-05, status=1, ipAttribution=)]
    2019-12-05 旺医

    顶刊就是顶刊,谢谢梅斯带来这么高水平的研究报道,我们科里同事经常看梅斯,分享梅斯上的信息

    0

相关资讯

Gut:贲门失弛缓症患者术后长期预后研究

研究认为,贲门失弛缓症患者接受气动扩张术10年的预后优于接受海勒肌切开术人群

Am J Gastroenterol:贲门失弛缓症的一线治疗方式是什么?

目的:贲门失弛缓症是食管动力障碍性疾病,是指吞咽后食管体部无蠕动、贲门括约肌弛缓不良的一种疾病。该疾病是慢性、渐进性、无法治愈的食管疾病。针对该疾病的一线治疗究竟是什么,目前临床上也不确定。本研究旨在评估比较,食道气囊扩张术 vs 腹腔镜下Heller肌切开伴部分胃底折叠术,对贲门失弛缓症相关生活质量的改善情况。 方法:这是一项前瞻性、多中心、随机试验,在加拿大的五家学术医院进行。研究纳入了

POEM治疗贲门失弛缓症1例报道

   疾病概述 贲门失弛缓症又称贲门痉挛、巨食管,是由于食管神经肌肉功能障碍所致的疾病,其主要特征是食管缺乏蠕动,食管下括约肌(LES)高压以及对吞咽动作的松弛反应减弱。 临床表现为咽下困难、食物反流和下端胸骨后不适,以及因食物反流误吸入气管所致咳嗽、肺部感染等症状。该病治疗不及时,有发生食管癌的潜在危险。 贲门失弛缓症的治疗目的在于降低LES压力,使食管下端松弛,

2018 ISDE指南:贲门失弛缓症

贲门失弛缓症是一种相对少见的原发性食管运动障碍性疾病,其主要特征是食管缺乏蠕动,食管下端括约肌(LES)高压和对吞咽动作的松弛反应减弱。临床表现为吞咽困难、胸骨后疼痛、食物反流以及因食物反流误吸入气管所致咳嗽、肺部感染等症状。本文主要针对贲门失弛缓症的诊断和管理提出了46条推荐意见。

Am J Gastroenterol:定时吞钡用于贲门失弛缓症、食管胃结流出道梗阻和非贲门失弛缓症吞咽困难的区分

研究认为,定时吞钡是简单有效的区分贲门失弛缓症、食管胃结流出道梗阻和非贲门失弛缓症吞咽困难的方法。5分钟钡高度>2cm是鉴别贲门失弛缓症的临界点。液体钡联合钡片可提高贲门失弛缓症和食管胃结流出道梗阻的诊断率。钡片单独保留则可提示食管胃交界处梗阻

邹多武:食管疾病研究热点

食管疾病是一种常见的消化道疾病,近年来,随着影像学技术、消化内镜技术及分子生物学的进步,食管疾病的临床诊疗有了较大的发展,同时也涌现出不少的热点问题,值得同道在今后的工作中进一步探讨。 (1)难治性胃食管反流病(GERD) GERD的处理一直是临床工作的难点,随着对食管测压技术的应用,发现部分难治性GERD患者可能存在食管运动障碍、贲门失弛缓症等动力障碍性疾病,而以往我国对嗜酸细胞

Baidu
map
Baidu
map
Baidu
map